SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------------------
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): May 13, 2002
-------------------------------
Response Oncology, Inc.
----------------------------
(Exact name of registrant as specified in its charter)
State of Tennessee 0-15416 62-1212264
- --------------------------- -------- --------------------
(State or other jurisdiction (Commission File No.) (I.R.S. Employer
of incorporation or organization) Identification No.)
1805 Moriah Woods Blvd.
Memphis, Tennessee 38117
---------------------------
(Address of Principal Executive
Offices)
(901) 761-7000
-------------------------------
(Registrant's telephone number,
including area code)
Item 5. Other Events.
On May 10, 2002, Response Oncology, Inc. and its wholly owned subsidiaries
(Response Oncology Management of South Florida, Inc., Response Oncology of Fort
Lauderdale, Inc. and Response Oncology of Tamarac, Inc.) (the "Company" or the
"Debtors") issued a press release announcing that the United States Bankruptcy
Court for the Western District of Tennessee, Western Division (the "Court"),
approved a disclosure statement filed in connection with the Joint Plan filed by
the Debtors and AmSouth Bank, as agent for itself, Bank of America, N.A. and
Union Planters Bank, N.A. on Friday, May 3, 2002. The press release is attached
as Exhibit 99.1 to this Form 8-K.
On May 9, 2002, the Company filed its monthly operating reports for the month of
February 2002 with the Court, a copy of which is filed herewith as Exhibit 99.2
to this Form 8-K. The carrying value of certain assets of the Company
(principally intangible assets) as of December 31, 2001, are subject to material
adjustments pending finalization of various sales transactions that recently
closed and completion of the Company's audit.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
99.1 Response Oncology, Inc. Press Release issued May 10, 2002.
99.2 Chapter 11 Monthly Operating Reports for February 2002 filed on May 9,
2002 by Response Oncology, Inc., Response Oncology Management of South
Florida, Inc., Response Oncology of Fort Lauderdale, Inc. and Response
Oncology of Tamarac, Inc., debtors-in-possession in Chapter 11 case
number 01-24607-DSK (jointly administered) in the United States
Bankruptcy Court for the Western District of Tennessee, Western
Division, in Memphis, Tennessee.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Response Oncology, Inc.
By: /s/ Peter A. Stark
Date: May 13, 2002 ----------------------------------------
Peter A. Stark, Executive Vice President,
Chief Financial Officer
EXHIBIT INDEX
Exhibit Number Description
99.1 Response Oncology, Inc. Press Release issued May
10, 2002.
99.2 Chapter 11 Monthly Operating Reports for February
2002 filed on May 9, 2002 by Response Oncology,
Inc., Response Oncology Management of South
Florida, Inc., Response Oncology of Fort
Lauderdale, Inc. and Response Oncology of
Tamarac, Inc., debtors-in-possession in Chapter
11 case number 01-24607-DSK (jointly
administered) in the United States Bankruptcy
Court for the Western District of Tennessee,
Western Division, in Memphis, Tennessee.